Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,364,401
+$824,917 QoQ
Shares Held
2,805
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#2,027
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. LLY ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,364,401 | 2,805 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,539,484 | 2,761 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,035,971 | 2,825 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,150,897 | 2,819 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,259,857 | 2,899 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,164,710 | 2,621 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,896,804 | 2,457 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,733,784 | 1,957 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,689,439 | 1,866 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,420,554 | 1,826 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $803,846 | 1,379 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $740,702 | 1,379 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $646,723 | 1,379 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $473,576 | 1,379 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $504,493 | 1,379 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $445,899 | 1,379 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $447,113 | 1,379 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $280,356 | 979 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $270,419 | 979 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $226,197 | 979 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $224,700 | 979 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $252,580 | 1,352 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $228,271 | 1,352 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $200,123 | 1,352 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $221,971 | 1,352 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $183,110 | 1,320 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||